MedPath

Effect of Intra-session Exercise Modes Sequence on Ventricular Function in Patients with Chronic Heart Failure

Not Applicable
Recruiting
Conditions
Heart Failure
Interventions
Other: resistance and aerobic training exercises
Registration Number
NCT06626542
Lead Sponsor
Cairo University
Brief Summary

The aim of this study was to investigate the effect of intra-session exercise modes sequence on ventricular function in patients with chronic heart failure.

Detailed Description

Sixty male patients with chronic heart failure will be recruited in this study from National Heart Institute Giza, Egypt. Their ages will be ranged from 55 to 65 years old and they will be randomly divided into three groups as following:

1. Study group (A) includes 20 patients who will receive intra-session exercise modes sequence of aerobic cardiovascular training (CVT) then resistance training (RT) exercises in addition to routine treatment programme.

2. Study group (B) includes 20 patients who will receive intra-session exercise modes sequence of resistance training (RT) then aerobic cardiovascular training (CVT) exercises in addition to routine treatment programme.

3. Control group (C) includes 20 patients who will receive routine treatment programme only.

The exercise training programme for both study groups A and B will be applied once per day, three times per week for 12 consecutive weeks.

Inclusion criteria:

All participated patients will be:

* Male patients with chronic heart failure and ages from 55 to 65 years old.

* Class II and class III heart failure according to NYHA classification.

* HFrEF category with LVEF \<40% as documented by echocardiogram within \<6 months.

* Receiving the same medical treatment programme for at least 3 months.

* Having a close level of functional capacity assessed by 6 minute walking test.

Exclusion criteria:

Patients who meet one of the following criteria will be excluded:

* Uncontrolled atrial fibrillation.

* Diabetes mellitus.

* Myocardial infarction or recurrent angina within \<3 months.

* Patients with chronic chest diseases.

* Severe stenotic valvular disease.

* Clinically significant peripheral vascular disease.

* Exercise-induced angina, ST segment changes or exercise induce AV block.

* Patients with chronic renal failure.

* Any cognitive impairment that interferes with prescribed exercise procedures.

* Musculoskeletal or neurological limitation to physical exercise.

RESEARCH ETHICS

The protocol of this study will be approved by the ethics committee of scientific research at the Faculty of Physical Therapy, Cairo University. The study procedure will be explained in details for every patient before the initial assessment. All patients will be informed about the purpose, nature, and potential risks of the study, and a written informed consent will be obtained before participation in the study. The participants' right confidentiality will be observed strictly.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
60
Inclusion Criteria
  • Male patients with chronic heart failure and ages from 55 to 65 years old.

    • Class II and class III heart failure according to NYHA classification.
    • HFrEF category with LVEF <40% as documented by echocardiogram within <6 months.
    • Receiving the same medical treatment programme for at least 3 months.
    • Having a close level of functional capacity assessed by 6 minute walking test
Exclusion Criteria
  • • Uncontrolled atrial fibrillation.

    • Diabetes mellitus.
    • Myocardial infarction or recurrent angina within <3 months.
    • Patients with chronic chest diseases.
    • Severe stenotic valvular disease.
    • Clinically significant peripheral vascular disease.
    • Exercise-induced angina, ST segment changes or exercise induce AV block.
    • Patients with chronic renal failure.
    • Any cognitive impairment that interferes with prescribed exercise procedures.
    • Musculoskeletal or neurological limitation to physical exercise.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
sequence of aerobic cardiovascular training (CVT) then resistance training (RT) exercisesresistance and aerobic training exercises-
sequence of resistance training (RT) then aerobic cardiovascular training (CVT) exercisesresistance and aerobic training exercises-
control group routine treatment programme onlyresistance and aerobic training exercises-
Primary Outcome Measures
NameTimeMethod
Left ventricular ejection fraction12 weeks

left ventricular ejection fraction is measured by using echocardiography it is measured in percentage %

Secondary Outcome Measures
NameTimeMethod
The Minnesota living with heart failure questionnaire (MLWHFQ)12 weeks

calculate minnasota living with heart failure questionnaire score 21 item MLHFQ uses a 6-point scale where 0 = no, 1= very little and 5= very much

Cardiorespiratory fitness 6 minute walk test12 weeks

after the test we calculate the distance patient walked in meters and we use this distance to evaluate the cardiopulmonary fitness

Vo2 Max12 week

by using distance from the 6MWT in meters we can calculate the vo2 max using specific equation

Blood pressure12 weeks

blood pressure systolic by using the sphygmomanometer palpatory method - diastolic by using the auscultatory method by sphygmomanometer and stethoscope

Rate of pressure product12 week

rate pressure product will be calculated by this equation : patient heart rate \* systolic blood pressure / 1000

Trial Locations

Locations (1)

National Heart Institute

🇪🇬

Giza, Agouza Giza Governorate, Egypt

© Copyright 2025. All Rights Reserved by MedPath